C

메타케어

118000KOSPI기계장비 및 관련 물품 도매업

48.0 / 100

Reference Date: 2026-06-10

Financial Score10.5 / 40
News Sentiment12.5 / 25
Momentum13.0 / 20
Disclosure12.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Surged 538.5% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

MetaCare operates across four business segments: Pharmaceuticals, Medical, Investment, and Real Estate Development, with the Pharmaceuticals segment contributing 77.2% of total revenue. The company has expanded its market presence through acquisitions, such as J&N Pharm and H Bio&Co, and achieved 2.8% revenue share from Real Estate Development in 2024.

Number of Employees

32people

Average Salary

65.7M KRW

Score Calculation Basis

Detailed Financial Score

PER
442.67Industry Average 10.160.0Point

43.6x industry avg (risky)

PBR
0.19Industry Average 0.647.0Point

Half of industry avg (excellent)

ROE
-0.18Industry Average 2.780.0Point

Well below industry avg

Debt Ratio
20.74Industry Average 6.760.0Point

3.1x industry avg (risky)

Trend 2023~20253.5 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼0.7% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲52.5% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -4.3% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50

Detailed Momentum

52-week position6.0Point

52w upper range (65%)

Current 1,328Won52-week high 1,90952-week low 208
1-month return6.0Point

1m +538.46% (strong rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

4 totalPositive 1Neutral 3Negative 0
  • Positive주요사항보고서(유상증자결정)2026-06-09
  • Neutral기업지배구조보고서공시2026-05-29
  • Neutral전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)2026-05-26
  • Neutral분기보고서 (2026.03)2026-05-15